Biocomposites Unveils Innovative SYNICEM™ Spacers
Biocomposites, a leader in medical devices, has launched its SYNICEM™ spacers in the United States. These ready-to-use, preformed antibiotic-loaded spacers are designed for hip, knee, and shoulder revision surgeries.
Revolutionizing Joint Revisions with SYNICEM™
The SYNICEM™ spacers are engineered to maintain joint stability and preserve articular space during complex two-stage revision procedures. They deliver a consistent local concentration of gentamicin, crucial for managing infection risks effectively.
Enhanced Efficiency in Surgical Procedures
Surgeons can utilize SYNICEM™ spacers in under a minute, eliminating the complications and time associated with handmade spacers. Their precision-engineered structure offers reliability, ensuring consistent performance throughout the surgery.
Variety and Flexibility in Design
Available in a wide array of sizes and designs, SYNICEM™ spacers accommodate unique patient needs. The range includes Charnley and Müller designs for hip surgeries, and specific shapes for left and right knees.
Proven Success Across the Globe
For over 20 years, SYNICEM™ spacers have been utilized successfully in over 70 countries. Their efficacy in saving surgical time and addressing challenging infection cases has made them a popular choice among surgeons.
Leadership Insights
Michael Harris, the CEO of Biocomposites, expressed his enthusiasm about the U.S. launch. He highlighted that SYNICEM™ spacers present a fast, straightforward, and reliable alternative to traditional spacers, making them invaluable in infection management.
About Biocomposites
Biocomposites is recognized for its pioneering work in medical devices focused on infection management in bone and soft tissue. Operating globally, the firm distributes its innovative calcium compounds and bone cements for various surgical applications. Their products facilitate bone regeneration and address infection risks in numerous medical fields, including orthopaedics and trauma.
With over a million procedures performed annually using their products, Biocomposites is critical in surgical advancements worldwide. The company is committed to enhancing surgical practices and improving patient outcomes.
Frequently Asked Questions
What are SYNICEM™ spacers?
SYNICEM™ spacers are preformed, antibiotic-loaded devices designed for use in joint revision surgeries, aimed at managing infection risks.
How do SYNICEM™ spacers work?
They deliver gentamicin locally during surgeries, providing effective infection management while preserving joint stability.
What advantages do SYNICEM™ spacers offer?
They are ready-to-use, precision-engineered, and eliminate the need for handmade spacers, thus enhancing efficiency in surgical procedures.
Who can benefit from using SYNICEM™ spacers?
Orthopaedic surgeons performing complex joint revisions can benefit from using SYNICEM™ spacers to improve patient outcomes.
Where can I learn more about Biocomposites?
To explore their products and innovations, visit their official website for detailed information and updates.
